[Usefulness of determining free estriol, placental lactogen, progesterone, placental alkaline phosphatase, uric acid, hematocrit, hemoglobin and proteins in the blood and estrogen in the urine in the prognosis of the status of newborn infants in EPH gestosis].
D000469:Alkaline Phosphatase; D004967:Estrogens / Q000097:blood / Q000652:urine; D005260:Female; D058851:GPI-Linked Proteins; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007231:Infant, Newborn / Q000502:physiology*; D007527:Isoenzymes / Q000097:blood; D010928:Placental Lactogen / Q000097:blood; D011225:Pre-Eclampsia / Q000378:metabolism*; D011247:Pregnancy; D011374:Progesterone / Q000097:blood; D011379:Prognosis; D014527:Uric Acid / Q000097:blood
D004967:Estrogens; D058851:GPI-Linked Proteins; D006454:Hemoglobins; D007527:Isoenzymes; D014527:Uric Acid; D011374:Progesterone; D010928:Placental Lactogen; D000469:Alkaline Phosphatase; C019839:alkaline phosphatase, placental
Ocena przydatności oznaczeń wolnego estriolu, laktogenu łozyskowego, progesteronu, łozyskowej fosfatazy alkalicznej, kwasu moczowego, hematokrytu, hemoglobiny i białka we krwi oraz estrogenów w moczu w prognozowaniu stanu noworodka w gestozie EPH.